Extrapyramidal symptoms upon discontinuation of fluoxetine.
Stoukides
J A
JA
Stoukides
C A
CA
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D003866:Depressive Disorder / Q000188:drug therapy; D004421:Dystonia / Q000139:chemically induced; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D014103:Torticollis / Q000139:chemically induced
D005473:Fluoxetine